These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 27528266)

  • 1. The Non-Linear Child: Ontogeny, Isoniazid Concentration, and NAT2 Genotype Modulate Enzyme Reaction Kinetics and Metabolism.
    Rogers Z; Hiruy H; Pasipanodya JG; Mbowane C; Adamson J; Ngotho L; Karim F; Jeena P; Bishai W; Gumbo T
    EBioMedicine; 2016 Sep; 11():118-126. PubMed ID: 27528266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of N-acetyltransferase 2 (NAT2) genotype/single nucleotide polymorphisms on clearance of isoniazid in tuberculosis patients: a systematic review of population pharmacokinetic models.
    Thomas L; Raju AP; Chaithra ; M SS; Varma M; Saravu K; Banerjee M; Sv CS; Mallayasamy S; Rao M
    Eur J Clin Pharmacol; 2022 Oct; 78(10):1535-1553. PubMed ID: 35852584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should we use N-acetyltransferase type 2 genotyping to personalize isoniazid doses?
    Kinzig-Schippers M; Tomalik-Scharte D; Jetter A; Scheidel B; Jakob V; Rodamer M; Cascorbi I; Doroshyenko O; Sörgel F; Fuhr U
    Antimicrob Agents Chemother; 2005 May; 49(5):1733-8. PubMed ID: 15855489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacogenetics of NAT2 enzyme maturation in perinatally HIV exposed infants receiving isoniazid.
    Zhu R; Kiser JJ; Seifart HI; Werely CJ; Mitchell CD; D'Argenio DZ; Fletcher CV
    J Clin Pharmacol; 2012 Apr; 52(4):511-9. PubMed ID: 21558457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NAT2 Genotype and Isoniazid Medication in Children.
    Golka K; Selinski S
    EBioMedicine; 2016 Sep; 11():11-12. PubMed ID: 27591833
    [No Abstract]   [Full Text] [Related]  

  • 6. Rapid identification of the NAT2 genotype in tuberculosis patients by multicolor melting curve analysis.
    Hu Y; Chen S; Yu X; Dai G; Dong L; Li Y; Zhao L; Huang H
    Pharmacogenomics; 2016 Jul; 17(11):1211-1218. PubMed ID: 27377479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors of isoniazid-induced hepatotoxicity in Tunisian tuberculosis patients.
    Ben Fredj N; Gam R; Kerkni E; Chaabane A; Chadly Z; Boughattas N; Aouam K
    Pharmacogenomics J; 2017 Jul; 17(4):372-377. PubMed ID: 27089936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of N-acetyltransferase 2 (NAT2), CYP2E1 and Glutathione-S-transferase (GST) genotypes on the serum concentrations of isoniazid and metabolites in tuberculosis patients.
    Fukino K; Sasaki Y; Hirai S; Nakamura T; Hashimoto M; Yamagishi F; Ueno K
    J Toxicol Sci; 2008 May; 33(2):187-95. PubMed ID: 18544910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A proposal for an individualized pharmacogenetic-guided isoniazid dosage regimen for patients with tuberculosis.
    Jung JA; Kim TE; Lee H; Jeong BH; Park HY; Jeon K; Kwon OJ; Ko JW; Choi R; Woo HI; Koh WJ; Lee SY
    Drug Des Devel Ther; 2015; 9():5433-8. PubMed ID: 26491254
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Mthiyane T; Millard J; Adamson J; Balakrishna Y; Connolly C; Owen A; Rustomjee R; Dheda K; McIlleron H; Pym AS
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31964788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Genetic Variation of
    Dompreh A; Tang X; Zhou J; Yang H; Topletz A; Adu Ahwireng E; Antwi S; Enimil A; Langaee T; Peloquin CA; Court MH; Kwara A
    Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29263072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-Acetyltransferase2 genotype correlated with isoniazid acetylation in Japanese tuberculous patients.
    Kita T; Tanigawara Y; Chikazawa S; Hatanaka H; Sakaeda T; Komada F; Iwakawa S; Okumura K
    Biol Pharm Bull; 2001 May; 24(5):544-9. PubMed ID: 11379777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Full-gene sequencing analysis of NAT2 and its relationship with isoniazid pharmacokinetics in Venezuelan children with tuberculosis.
    Verhagen LM; Coenen MJ; López D; García JF; de Waard JH; Schijvenaars MM; Hermans PW; Aarnoutse RE
    Pharmacogenomics; 2014 Feb; 15(3):285-96. PubMed ID: 24533708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trimodality of isoniazid elimination: phenotype and genotype in patients with tuberculosis.
    Parkin DP; Vandenplas S; Botha FJ; Vandenplas ML; Seifart HI; van Helden PD; van der Walt BJ; Donald PR; van Jaarsveld PP
    Am J Respir Crit Care Med; 1997 May; 155(5):1717-22. PubMed ID: 9154882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenetic testing for NAT2 genotypes in a Tanzanian population across the lifespan to guide future personalized isoniazid dosing.
    Masiphephethu MV; Sariko M; Walongo T; Maro A; Mduma D; Gratz J; Alshaer M; Peloquin CA; Mduma E; Mpagama SG; Thomas T; Houpt ER; Traore A; Bessong P; Heysell SK; Operario DJ
    Tuberculosis (Edinb); 2022 Sep; 136():102246. PubMed ID: 35961094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotype and allele frequencies of isoniazid-metabolizing enzymes NAT2 and GSTM1 in Latvian tuberculosis patients.
    Igumnova V; Capligina V; Krams A; Cirule A; Elferts D; Pole I; Jansone I; Bandere D; Ranka R
    J Infect Chemother; 2016 Jul; 22(7):472-7. PubMed ID: 27236516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NAT2 genotype guided regimen reduces isoniazid-induced liver injury and early treatment failure in the 6-month four-drug standard treatment of tuberculosis: a randomized controlled trial for pharmacogenetics-based therapy.
    Azuma J; Ohno M; Kubota R; Yokota S; Nagai T; Tsuyuguchi K; Okuda Y; Takashima T; Kamimura S; Fujio Y; Kawase I;
    Eur J Clin Pharmacol; 2013 May; 69(5):1091-101. PubMed ID: 23150149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of N-acetyltransferase 2 genotype with isoniazid acetylation in Polish tuberculosis patients.
    Zabost A; Brzezińska S; Kozińska M; Błachnio M; Jagodziński J; Zwolska Z; Augustynowicz-Kopeć E
    Biomed Res Int; 2013; 2013():853602. PubMed ID: 24383060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-distribution and genotype-phenotype correlation for N-acetyltransferase in Argentine children under isoniazid treatment.
    Keller GA; Fabian L; Gomez M; Gonzalez CD; Diez RA; Di Girolamo G
    Int J Clin Pharmacol Ther; 2014 Apr; 52(4):292-302. PubMed ID: 24447650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Rapid Pharmacogenomic Assay to Detect
    Verma R; Patil S; Zhang N; Moreira FMF; Vitorio MT; Santos ADS; Wallace E; Gnanashanmugam D; Persing DH; Savic RM; Croda J; Andrews JR
    Am J Respir Crit Care Med; 2021 Dec; 204(11):1317-1326. PubMed ID: 34375564
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.